Back to search

Stevenage Bioscience Catalyst

07196230

active
private limited guarant nsc limited exemption
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Loss before tax (-10)
  • Going concern doubt noted in accounts (-10)

Details

Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, SG1 2FX
Incorporated 19/03/2010

Previously known as

Stevenage Bioscience Park · until 02/08/2010

Compliance

Last accounts

31/03/2025

full

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 19/03/2026

Due 02/04/2027

On track

Industry

82990
Other business support service activities

Officers

Jonathan Alexander Green

director · Since 30/08/2019

British · United Kingdom · Age 69

Ann Jacqueline Hunter

director · Since 01/09/2020

British · England · Age 69

Uday Prabhakar Phadke

director · Since 03/04/2023

British · United Kingdom · Age 74

Lynn Drummond

director · Since 01/05/2023

British · England · Age 66

Former

Allan Baxter

director · Resigned 06/01/2015

John Cooper

director · Resigned 05/07/2016

Daniel Nelki

director · Resigned 05/04/2017

Martino Picardo

director · Resigned 23/06/2017

Iain Stuart Ward

director · Resigned 31/07/2018

Ian Michael Tomlinson

director · Resigned 31/08/2020

Dave Allen

director · Resigned 31/08/2020

Veronique Anne Bouchet

director · Resigned 07/06/2022

Clare Elizabeth Terlouw

director · Resigned 11/01/2023

James Russell Wheatcroft

director · Resigned 20/07/2023

Sally Ann Forsyth

director · Resigned 02/05/2026

Graham Paul Rivers

director · Resigned 20/05/2026

Persons with Significant Control

Glaxosmithkline Research & Development Limited

25–50% votes

79, New Oxford Street, London, WC1A 1DG

Reg: 00835139 · Companies House · Private Limited Company By Shares

Notified 06/04/2016

The Wellcome Trust Limited

25–50% votes

Gibbs Building, 215, Euston Road, London, NW1 2BE

Reg: 02711000 · Companies House · Private Company Limited By Guarantee Without Share Capital

Notified 06/04/2016

Charges0 outstanding

charge
satisfied

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED

Created 22/12/2011Registered 24/12/2011Satisfied 01/08/2023
charge
satisfied

THE WELLCOME TRUST LIMITED

Created 22/12/2011Registered 24/12/2011Satisfied 01/08/2023
charge
satisfied

EAST OF ENGLAND DEVELOPMENT AGENCY

Created 22/12/2011Registered 24/12/2011Satisfied 01/08/2023

Change History

statusactive
2026-06-07

Active

typeprivate-limited-guarant-nsc-limited-exemption
2026-06-07

PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)

address line1Stevenage Bioscience Catalyst
2026-06-07

STEVENAGE BIOSCIENCE CATALYST

post townStevenage
2026-06-07

STEVENAGE

CompanyRankvs 6551+ SIC 82990 peers
72

Financial strength99th percentile among SIC peers · 25/25
Employees97th percentile among SIC peers · 15/15
LiquidityCurrent ratio 1.06× · 12/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co

Key FinancialsYear ending 31/03/2025

Turnover

£4.1M

Annual revenue

Net Worth

£4.3M

Balance sheet strength

Cash

£1.5M

Cash in the bank

Profit Before Tax

-£884k

Bottom line earnings

Net Current Assets

£192k

Working capital

Current Assets

£3.6M

Current Liabilities

£3.4M

Fixed Assets

£18.4M

Debtors

£2.1M

Gross Profit

£4.1M

Admin Expenses

£6.2M

Operating Profit

-£986k

Profit After Tax

-£683k

17avg. employees

Tax at Year End

Corp tax£167k

Balance Sheet

Assets less current liabilities£18.6M
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20251.06-£683k
20241.52

Derived from filed accounts. Not audited figures.